FdaApplication
ANDA 202937
Identifiers
- fda_app_no: ANDA202937
Properties
| Property | Value |
|---|---|
| applicant_name | ORBION PHARMACEUTICALS PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2015-03-02 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLANZAPINE | OLANZAPINE | 5MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| OLANZAPINE | OLANZAPINE | 15MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| OLANZAPINE | OLANZAPINE | 10MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| OLANZAPINE | OLANZAPINE | 20MG | TABLET, ORALLY DISINTEGRATING;ORAL |
4 products